There was no significant difference in the number of NPC-derived YFP+ cells that differentiated into GFAP+ astrocytes following NWL283 treatment compared to stroke+vehicle mice (p = 0.772) (Figure 3E). The gene discussed is GFAP; the disease is stroke disorder.